Effect of the Disulfide Bridge and the C-Terminal Extension on the Oligomerization of the Amyloid Peptide ABri Implicated in Familial British Dementia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“synthetic ABri peptide, especially the oligomeric form, induces apoptotic cell death in vitro while the wild type peptide is not toxic to cells (30,31).”
From Proteolytic Processing of Familial British Dementia-associated BRI Variants (2002) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466
Research works printed but not linked: 48
- Worster-Drought C., 1933, J. Neurol. Psychopathol., 14, 34
- Plant G. T., 1990, Brain 113, 721−747
- Aikawa H., 1985, Ann. Neurol. 17, 297−300
- Vidal R., 1999, Nature 399, 776−781
- Kim S. H., 1999, Nat. Neurosci. 11, 984−988
- El-Agnaf O. M. A., 2000, J. Struct. Biol., 130
- Johnson W. G., 2000, J. Anat., 196, 10.1046/j.1469-7580.2000.19640609.x · DOI · Paper page
- Perutz M. F., 1999, Trends Biochem. Sci., 24, 63, 10.1016/S0968-0004(98)01350-4 · DOI · Paper page
- El-Agnaf O. M. A., 2000, Pept. Protein Lett., 7, 8
- El-Agnaf O. M. A., 1998, Eur. J. Biochem., 256
- Haris P. I., 1986, Biochim. Biophys. Acta, 874, 10.1016/0167-4838(86)90024-5 · DOI
- Haris P. I., 2000, ACS Symp. Ser., 750, 95
- Guex N., 1997, Electrophoresis 18, 2714−2723
- Peterson S. A., 1998, Proc. Natl. Acad. Sci. U.S.A. 95, 12956−12960
- Hutchinson E. G., 1998, Protein Sci. 11, 2287−2300
- Rodriguez R., 1998, Bioinformatics 14, 523−528
- Hooft R. W. W., 1996, Nature, 381, 272, 10.1038/381272a0 · DOI · Paper page
- Ladewig P., 1945, Nature, 156, 81, 10.1038/156081a0 · DOI
- Cooper J. H., 1974, Lab. Invest. 31, 232−238
- Elghetany M. T., 1988, Stain Technol. 63, 201−212
- El-Agnaf O. M. A., 1998, Eur. J. Biochem., 256
- Conway, K. A., Harper, J. D., and Lansbury, P., Jr. (2000)Biochemistry39, 2552−2563. · DOI · Paper page
- Walsh D. M., 1997, J. Biol. Chem., 272, 10.1074/jbc.272.35.22364 · DOI · Paper page
- Haris P. I., 1992, Trends Biochem. Sci. 17, 328−333
- Haris P. I., 1998, Biosci. Rep. 18, 299−312
- Cuff J. A., 1998, Bioinformatics 14, 892−893
- Jones D. T., 1999, J. Mol. Biol., 292, 10.1006/jmbi.1999.3091 · DOI · Paper page
- Gunasekaran K., 1997, Protein Eng. 10, 1131−1141
- Hutchinson E. G., 1994, Protein Sci. 12, 2207−2216
- El-Agnaf O. M. A., 2000, Biochem. Biophys. Res. Commun. 273, 1003−1007
- Roher A. E., 1996, J. Biol. Chem., 271, 10.1074/jbc.271.34.20631 · DOI · Paper page
- Pitschke M., 1998, 4, 832−834
- Hartley D. M., 1999, J. Neurosci., 19, 10.1523/JNEUROSCI.19-20-08876.1999 · DOI · Paper page
- Harper J. D., 1999, Biochemistry 38, 8972−8980
- Lansbury P. T., Jr., 1999, Proc. Natl. Acad. Sci. U.S.A. 96, 3342−3344
- Saudou F., 1998, Cell 271
- Conway K. A., 2000, Proc. Natl. Acad. Sci. U.S.A. 97, 571−576
- Bhatia R., 2000, FASEB J., 14, 10.1096/fasebj.14.9.1233 · DOI · Paper page
- Zhu Y. J., 2000, FASEB J., 14
- Sian A. K., 2000, Biochem. J., 349
- Plant G. T., 1990, Brain 113, 721−747
- Vidal R., 2000, Proc. Natl. Acad. Sci. U.S.A. 97, 4920−4925
- El-Agnaf O. M. A., 1998, Biochem. J., 336
- El-Agnaf O. M. A., 1998, FEBS Lett., 440, 75
- Pan K. M., 1993, Proc. Natl. Acad. Sci. U.S.A. 90, 10962−10966
- El-Agnaf O. M. A., 1998, FEBS Lett., 440, 70
- Serpell L. C., 2000, Proc. Natl. Acad. Sci. U.S.A. 97, 4897−4902
- Abbreviations AD, Alzheimer's disease
Cited by
Kirkitadze, M. D., Bitan, G., & Teplow, D. B. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10328 · Cited by 585
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Lashuel, H. A., & Lansbury, P. T. (2006) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583506004422 · Cited by 400
Prediction of the Absolute Aggregation Rates of Amyloidogenic Polypeptide Chains
DuBay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M., & Vendruscolo, M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.043 · Cited by 318
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
Majbour, N. K., Vaikath, N. N., van Dijk, K. D., Ardah, M. T., Varghese, S., Vesterager, L. B., Montezinho, L. P., Poole, S., Safieh-Garabedian, B., Tokuda, T., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0072-9 · Cited by 277
Self-citationProteolytic Processing of Familial British Dementia-associated BRI Variants
Kim, S.-H., Creemers, J. W. M., Chu, S., Thinakaran, G., & Sisodia, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108739200 · Cited by 63
Metadata
- Authors
- El-Agnaf, O. M. A., Sheridan, J. M., Sidera, C., Siligardi, G., Hussain, R., Haris, P. I., & Austen, B. M.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2001-03-01
- Volume
- 40
- Issue
- 12
- Pages
- 3449-3457
- ISSN
- 0006-2960
- 1520-4995
- Cited by
- 45
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of the Disulfide Bridge and the C-Terminal Extension on the Oligomerization of the Amyloid Peptide ABri Implicated in Familial British Dementia. https://app.cochat.ai/papers/10.1021/bi002287i
- The paper
- El-Agnaf, O. M. A., Sheridan, J. M., Sidera, C., Siligardi, G., Hussain, R., Haris, P. I., & Austen, B. M. (2001). Effect of the Disulfide Bridge and the C-Terminal Extension on the Oligomerization of the Amyloid Peptide ABri Implicated in Familial British Dementia. Biochemistry. https://doi.org/10.1021/bi002287i
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.